title: Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests.
authors: Division of Infectious Diseases, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA. drormc@hotmail.com
authors: Dror
authors: D
authors: Marchaim
authors: Bharath
authors: B
authors: Sunkara
authors: Paul R
authors: PR
authors: Lephart
authors: Uma Mahesh
authors: UM
authors: Gudur
authors: Ashish
authors: A
authors: Bhargava
authors: Ryan P
authors: RP
authors: Mynatt
authors: Jing J
authors: JJ
authors: Zhao
authors: Suchitha
authors: S
authors: Bheemreddy
authors: Kayoko
authors: K
authors: Hayakawa
authors: Teena
authors: T
authors: Chopra
authors: Sorabh
authors: S
authors: Dhar
authors: Keith S
authors: KS
authors: Kaye
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000077723:Cefepime; D002444:Cefuroxime / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D010878:Piperacillin / Q000494:pharmacology; D000077725:Piperacillin, Tazobactam Drug Combination; D001618:beta-Lactamases / Q000096:biosynthesis
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000077725:Piperacillin, Tazobactam Drug Combination; D000077723:Cefepime; D010397:Penicillanic Acid; D001618:beta-Lactamases; D002444:Cefuroxime; D010878:Piperacillin